Skip to content
S1002Senate2023-2024 Session

Cover STD Home Test Kits

Official title

“Requires insurance coverage for home test kits for sexually transmitted diseases”

Sponsor Brad Hoylman-SigalSD-47+1 co-sponsorAffects Finance
Status
In Senate Committee
Insurance
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires New York health insurance policies to cover home test kits for sexually transmitted diseases, including HIV.

Why it matters

  1. Expands access to STD testing. By requiring insurance coverage for home test kits, this bill aims to make it easier and more convenient for individuals to get tested for sexually transmitted diseases, potentially reducing barriers like stigma, transportation, or time off work.

  2. Targets public health priorities. The bill specifically covers tests recommended by authoritative bodies such as the CDC and the U.S. Preventive Services Task Force, ensuring that only evidence-based, high-impact tests are included—helping to identify and treat infections earlier and reduce community spread.

  3. Ensures test quality and reliability. By limiting coverage to home test kits that are FDA-approved, CLIA-waived, or developed by regulated labs, the law seeks to protect consumers from unproven or low-quality products, ensuring that results are accurate and actionable.

  4. Applies broadly across insurance types. The amendments affect multiple types of insurance policies (hospital, surgical, medical, and those that reimburse for lab or X-ray services), making the coverage change widespread and impacting a large number of New Yorkers.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Health insurers

    The bill would require policies providing the specified medical or diagnostic coverage to cover qualifying home test kits for sexually transmitted diseases.

  • Insured people seeking STD testing

    The bill would require coverage for qualifying kits that let individuals collect their own specimens outside a clinical setting, including for HIV testing.

  • Home test kit manufacturers and laboratories

    Their products could qualify for required coverage if they meet the bill’s test-recommendation and regulatory or laboratory quality criteria.

Headline styles

Cover STD Home Test Kits

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Brad Hoylman-Sigal

Senator · Senate District 47

Chair, Judiciary

1 Co-sponsor

History

  1. Referred to insurance
  2. Referred to insurance

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1002

2023-2024 Regular Sessions

IN SENATE

January 9, 2023

Introduced by Sens. HOYLMAN, MYRIE -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance

AN ACT to amend the insurance law, in relation to requiring health insurance coverage for home test kits for sexually transmitted diseases

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows:

(39) Every policy which provides hospital, surgical or medical coverage or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for home test kits for sexually transmitted diseases. For purposes of this paragraph, "home test kit" means a product used for a test recommended by the federal Centers for Disease Control and Prevention guidelines or the United States Preventive Services Task Force, that has been Clinical Laboratory Improvement Amendments of 1988-waived, cleared or approved by the United States Food and Drug Administration, or developed by a laboratory in accordance with established regulations and quality standards, to allow individuals to self-collect specimens for sexually transmitted diseases, including HIV, remotely at a location outside of a clinical setting.

§ 2. Subsection (k) of section 3221 of the insurance law is amended by adding a new paragraph 23 to read as follows:

(23) Every policy which provides hospital, surgical or medical coverage or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for home test kits for sexually transmitted diseases. For purposes of this paragraph, "home test kit" means a product used for a test recommended by the federal Centers for Disease Control and Prevention guidelines or the United States Preventive Services Task Force, that has been Clinical Laboratory Improvement Amendments of 1988-waived, cleared or approved by the United

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD04068-01-3

States Food and Drug Administration, or developed by a laboratory in accordance with established regulations and quality standards, to allow individuals to self-collect specimens for sexually transmitted diseases, including HIV, remotely at a location outside of a clinical setting.

§ 3. Section 4303 of the insurance law is amended by adding a new subsection (uu) to read as follows:

(uu) Every policy which provides hospital, surgical or medical coverage or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for home test kits for sexually transmitted diseases. For purposes of this subsection, "home test kit" means a product used for a test recommended by the federal Centers for Disease Control and Prevention guidelines or the United States Preventive Services Task Force, that has been Clinical Laboratory Improvement Amendments of 1988-waived, cleared or approved by the United States Food and Drug Administration, or developed by a laboratory in accordance with established regulations and quality standards, to allow individuals to self-collect specimens for sexually transmitted diseases, including HIV, remotely at a location outside of a clinical setting.

§ 4. This act shall take effect on the ninetieth day after it shall have become a law and shall apply to any policy issued, delivered, renewed, and/or modified on or after the effective date of this act. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the insurance law, in relation to requiring health insurance coverage for home test kits for sexually transmitted diseases

Purpose

To require insurance providers cover at home STD test kits.

Summary of specific provisions

Section 1 of the bill amends section 3216 of insurance law section to require insurance policies include coverage for STD home test kits.

Section 2 of the bill amends section 3216 of insurance law section to require insurance policies include coverage for STD home test kits.

Section 3 of the bill amends section 3216 of insurance law section to require insurance policies include coverage for STD home test kits.

Section.4 is the effective date.

Justification

Rates of sexually transmitted diseases (STDs) have been trending upward, with reported STDs reaching an all-time high for the sixth year in a row, according to the Centers for Disease Control and Prevention. A recent report found a nearly thirty percent increase in reported STDs between 2015 and 2019. Alarmingly, the most recent data available for 2020 suggests that this trend has only gotten worse, but the COVID-19 pandemic has disrupted our STD testing protocols and staffing capacity, which has left us in the dark about the true state of this parallel epidemic.

The lack of easily available and convenient testing has also contributed to undetected infections that in turn increase the rate of spread of these diseases. While many of these illnesses are treatable, some do not manifest symptoms for extended periods. Without testing, individuals do not seek treatment and are in danger of fatal or severe health conse- quences. This bill helps ensure New York can control the spread and provide treatment for those in need by making convenient at home testing widely available.

Legislative history

None.

Fiscal implications

S.8187 of 2021-2022 (Hoylman): Died in Insurance

Effective date

This act shall take effect on the ninetieth day after it shall have become a law and shall apply to any policy issued, delivered, renewed, and/or modified on or after the effective date of this act. Effective immediately, the addition, amendment and/or repeal of any rule or regu- lation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.